Purdue Frederick clinical trials

Acquired by Knoa Pharma, May 1, 2026 · source ↗

The registry lists 1 studies whose lead sponsor is Purdue Frederick. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 24, 2005.

Before and after it joined Knoa Pharma

First submitted before Purdue Frederick became part of Knoa Pharma: 1
First submitted after Purdue Frederick became part of Knoa Pharma: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 1

Phase

Phase 1: 1

Where

United States: 1

Registry sponsor names on this page

Purdue Frederick1 study

Something wrong with this grouping? Tell us on the Knoa Pharma page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Knoa Pharma studies →

Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) InfectionCompletedNCT00002078Phase 1
Sponsor listed in the registry: Purdue Frederick · First submitted before Purdue Frederick became part of Knoa Pharma